HPS to manufacture medicines for phase IIB psychosis treatment clinical trial
Huddersfield Pharmacy Specials (HPS) is delighted to announce that the business has been selected to formulate and manufacture active and placebo medicines for a pragmatic, multicentre, randomised controlled trial of active versus placebo in patients clinically at high-risk of developing psychosis. HPS will be responsible for and advising upon the investigational medicinal product dossier (IMPD), […]

